Eosinophilia secondary to lenalidomide therapy
Escudero‐Vilaplana, V., Osorio‐Prendes, S., Collado‐Borrell, R., González‐Arias, E., Sanjurjo‐Sáez, M.
Published in Journal of clinical pharmacy and therapeutics (01.04.2018)
Published in Journal of clinical pharmacy and therapeutics (01.04.2018)
Get full text
Journal Article
Impact of medication adherence on the effectiveness of deferasirox for the treatment of transfusional iron overload in myelodysplastic syndrome
Escudero-Vilaplana, V., Garcia-Gonzalez, X., Osorio-Prendes, S., Romero-Jimenez, R. M., Sanjurjo-Saez, M.
Published in Journal of clinical pharmacy and therapeutics (01.02.2016)
Published in Journal of clinical pharmacy and therapeutics (01.02.2016)
Get full text
Journal Article
5PSQ-048 Analysis of drug interactions between oral antineoplastic agents and concurrent medications
Narrillos-Moraza, A, Escudero-Vilaplana, V, Collado-Borrell, R, Hoyo-Muñoz, A, Gimenez-Manzorro, A, Amor-Garcia, MA, Osorio-Prendes, S, Calles-Blanco, A, Herranz-Alonso, A, Sanjurjo-Saez, M
Published in European journal of hospital pharmacy. Science and practice (01.03.2020)
Published in European journal of hospital pharmacy. Science and practice (01.03.2020)
Get full text
Journal Article
PS1186 CURRENT DOSE RECOMMENDATIONS FOR PONATINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS CAN DIMINISH ADVERSE EVENTS WHILE MAINTAINING EFFICACY
Garcia‐Gutierrez, V., Hernandez‐Boluda, J.C., Moiraghi, B., Sacha, E.S. Tomasz, Pavlovsky, C., Grzybowska‐Izydorczyk, O., Correa, J., Lopez, R. Perez, Góra‐Tybor, E.P. Joanna, Garcia, A. Novo, Prendes, S. Osorio, Vallansot, R., Payer, A. Ramirez, Wasilewska, E., Villaespesa, M. Piris, Genovard, C. Boque, Encinas, M. Perez, Velasco, A. Jimenez, Sanchez‐Guijo, F., Collada, M.A. Romo, Casares, M.T. Gomez, Pascual, G. Orti, Duran, M.S., Portero, A., Mata, M.I., Noya, M.S., Caballero, G., Garcia, N., Castro, D. Robles, Ramirez, M.J., Magan, A. Senin, Lakhwani, S., Dominguez, J.M. Alonso, Montero, M.I., Chulvi, M.J. Lis, Ciepłuch, H., Steegman, J.L.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
CP-005 Association between medication adherence and effectiveness in the use of deferasirox for the treatment of transfusional iron overload in myelodysplastic syndrome
Escudero-Vilaplana, V, Mejias-Gomez, O, de la Encina, J Leal, Osorio-Prendes, S, Garcia-Gonzalez, X, Romero-Jimenez, RM, Rodriguez-Gonzalez, CG, Tovar-Pozo, M, Herranz-Alonso, A, Sanjurjo-Saez, M
Published in European journal of hospital pharmacy. Science and practice (01.03.2016)
Published in European journal of hospital pharmacy. Science and practice (01.03.2016)
Get full text
Journal Article
DI-002 Effectiveness and safety of deferasirox in the treatment of transfusional iron overload in myelodysplastic syndrome in clinical practice
Escudero-Vilaplana, V, Mejias-Gomez, O, Encina, J Leal de La, Gonzalez-Garcia, X, Osorio-Prendes, S, Romero-Jimenez, RM, Tovar-Pozo, M, Ais-Larisgoitia, A, Herranz-Alonso, A, Sanjurjo-Saez, M
Published in European journal of hospital pharmacy. Science and practice (01.03.2016)
Published in European journal of hospital pharmacy. Science and practice (01.03.2016)
Get full text
Journal Article